Non-interventional, Observational, Long Term Study to Evaluate Common Therapeutic Algorithms and Possible Predictive Parameters for Somatuline Autogel (ATG) Treatment in Patients With Acromegaly.

Trial Profile

Non-interventional, Observational, Long Term Study to Evaluate Common Therapeutic Algorithms and Possible Predictive Parameters for Somatuline Autogel (ATG) Treatment in Patients With Acromegaly.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2015

At a glance

  • Drugs Lanreotide (Primary)
  • Indications Acromegaly
  • Focus Pharmacodynamics
  • Acronyms TAPAS
  • Sponsors Ipsen
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Sep 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 03 Nov 2014 Planned End Date changed from 1 Jul 2020 to 1 Aug 2020 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top